All Activity

I admire this article for the well-researched content and excellent wording. I got so involved in this material that I couldn’t stop reading. I am impressed with your work and skill. Thank you so much. taxi weybridge to heathrow near me

Many clients prefer Escorts in South Delhi because the companions are stylish, intelligent, and naturally charming. Their warm nature and graceful presence help create an enjoyable experience filled with comfort and relaxation.

I really like your take on the issue. I now have a clear idea on what this matter is all about.. walton airport taxi

I have read your article, it is very informative and helpful for me.I admire the valuable information you offer in your articles. Thanks for posting it.. minicab airport walton near me

Thanks for a wonderful share. Your article has proved your hard work and experience you have got in this field. Brilliant .i love it reading. rail taxi walton near me

If you are a man of distinction and visiting Karol bagh district in Delhi for the first time, you must be looking for the best adult entertainment. We're here to make that happen. Our Escort Service in Karol Bagh are known for their beauty, charm, and their art of entertaining men. Our sexy call girls will bewitch you with their voluptuous figure and captivating presence. Whether it's college kids or celebrity, our offerings are catered to all tastes and preferences. Savor luxury without the hassles and with no price tag!

Marijuana Moment is asking a Drug Enforcement Administration (DEA) judge to reconsider his decision to prohibit livestraming of a hearing on the Trump administration’s cannabis rescheduling proposal that is scheduled to begin next week and that features only opponents of the reform as invited participants. Chief Administrative Law Judge Derek Julis last week issued a preliminary order laying out rules and timelines for the marijuana rescheduling proceedings—simultaneously recognizing that “national public interest in this issue predicates towards a policy of transparency” while also determining that “the hearing will not be televised, livestreamed, or broadcasted in any way.” As a result, people who wish to observe the historic cannabis reform process must attend in person in Arlington, Virginia under the judge’s order. In a letter sent to Julius on Tuesday, Marijuana Moment counsel Joseph Bondy noted that DEA permitted livestreaming of an earlier, subsequently cancelled hearing process on the proposal to move cannabis from Schedule I of the Controlled Substances Act (CSA) to Schedule III that took place during the Biden administration. “That prior determination was correct. The public-interest rationale for contemporaneous access has not diminished,” Bondy wrote. “If DEA believes safety, witness-management, or operational concerns now require a more restrictive access regime, those concerns should be identified and addressed through narrow conditions rather than a categorical ban.” “Limited physical seating in Arlington is not a meaningful substitute for livestreaming. Marijuana Moment, like many members of the press and public who follow federal cannabis policy nationally, cannot rely on a handful of available seats as a practical means of observing and reporting on the hearing. That is precisely why DEA’s prior livestreaming directive mattered: it allowed those physically outside the courtroom to observe the proceeding without disrupting the hearing, burdening security, or conferring party status on anyone.” “In a proceeding of this public significance, and in light of DEA’s prior livestreaming directive, a public hearing is not meaningfully public if access depends on the happenstance of limited physical attendance,” Marijuana Moment’s attorney wrote to the DEA judge. “Delayed access to transcripts is no substitute for contemporaneous observation. The press reports events as they unfold. The public evaluates government action in real time. And in a proceeding of this magnitude, transparency is not a courtesy. It is a safeguard.” “For a substantial public audience seeking serious coverage of federal cannabis policy, Marijuana Moment is an important channel through which public understanding of this proceeding occurs.” The letter makes clear that Marijuana Moment “does not seek to participate as a party, present evidence, examine witnesses, submit proposed findings, or alter the merits schedule” and “seeks only contemporaneous public and press access to an administrative hearing of recognized national public interest.” Bondy requested a response from Julius by Thursday. — Marijuana Moment’s journalism is made possible by readers like you who value this work enough to support us with monthly pledges on Patreon. If you rely on our reporting to stay informed about key cannabis developments, please help us keep doing this by becoming a sustaining subscriber today. Backing us at the $25/month level also gets you access to our Bill Tracker so you won’t miss any important marijuana legislation in your state. — Meanwhile, the attorney is also representing a major cannabis reform organization that is asking DEA to reconsider the decision to exclude it from participating in the hearing as an interested party. The National Organization for the Reform of Marijuana Laws (NORML), which represents the interests of people who use cannabis, filed the “emergency request for reconsideration” on Friday through Bondy, saying that the “public interest will be substantially harmed if the record omits the consumer perspective.” DEA last week announced that it had selected participants for the marijuana rescheduling hearing—and only opponents of the reform have been invited to take part, some of whom have filed litigation in an attempt to block the reform. No reform supporters who expressed intent to participate were invited. “NORML’s exclusion, if not corrected immediately, will deprive NORML and the cannabis consumers it represents of meaningful participation in prehearing procedures, witness presentation, exhibit designation, cross-examination, legal briefing, and any other proceedings necessary to compile a complete record,”Bondy, who serves as chair of NORML’s board of directors, wrote to DEA Administrator Terrance Cole. “The prejudice is immediate. It cannot be cured after the hearing closes.” According to several rejection letters Marijuana Moment has seen from cannabis reform supporters, DEA said they do not meet the definition of an “interested person” to participate because they are not “adversely affected or aggrieved by any rule or proposed rule issuable.” NORML said in its request for reconsideration, however, that “DEA’s denial rests on a mistaken premise: that NORML is not adversely affected or aggrieved by the proposed rule because NORML supports removing marijuana from schedule I and recognizes that schedule III is preferable to schedule I.” “That is not NORML’s position. NORML supports removal from schedule I. But NORML does not concede that schedule III is the correct final federal treatment for marijuana,” Bondy wrote. “NORML’s position is that marijuana should be removed from the CSA schedules and regulated under a cannabis-specific federal framework directed to public health, consumer safety, product integrity, youth prevention, truthful labeling, testing, research access, impaired-driving policy, anti-diversion, state-regulated market realities, and illicit-market displacement.” The attorney wrote that the injury from Schedule III status for marijuana is “not mere ideological disappointment.” “NORML’s members would remain subject to federal controlled-substance status and the legal consequences that flow from it. Adult-use consumers who lawfully participate in state-regulated markets would remain outside coherent federal recognition,” Bondy said. “Schedule III would preserve federal illegality for cannabis activity outside federally authorized medical, research, or registrant channels. It would continue federal-state conflict, public confusion, stigma, collateral consequences, and consumer-safety harms.” The hearing will begin on June 29 and is set to conclude no later than July 15. Acting Attorney General Todd Blanche in April issued an order that immediately reclassified state-licensed medical cannabis, as well as marijuana products approved by the Food and Drug Administration (FDA) from Schedule I of the Controlled Substances Act (CSA) to Schedule III. Under a separate order the acting attorney general signed, the upcoming hearing will consider more comprehensively moving marijuana to Schedule III. In order to be considered for participation in the hearing, parties needed to file requests articulating their interest in the proceeding, the objections or issues they wish to be heard on and their position on those issues. “The purpose of the hearing is to ‘receiv[e] factual evidence and expert opinion regarding’ whether marijuana should be transferred to schedule III of the list of controlled substances,” Blanche’s initial notice, filed in April, said. The attorney general also selected an administrative law judge (ALJ) to oversee the proceedings. “The ALJ’s authorities include the power to hold conferences to simplify or determine the issues in the hearing or to consider other matters that may aid in the expeditious disposition of the hearing; require parties to state their position in writing; sign and issue subpoenas to compel the production of documents and materials to the extent necessary to conduct the hearing; examine witnesses and direct witnesses to testify; receive, rule on, exclude, or limit evidence; rule on procedural items; and take any action permitted by the presiding officer under DEA’s hearing procedures and the” Administrative Procedures Act, Blanche wrote. A prior hearing process on the marijuana rescheduling process that was initiated by the Biden administration stalled last year amid litigation over alleged improper communications and witness selection. The current marijuana rescheduling process is being challenged with several lawsuits that have been consolidated by a federal appeals court. Those pieces of litigation against the cannabis reform have been filed by state attorneys general, marijuana legalization opponents and a cannabis-focused biopharmaceutical corporation. Meanwhile, the already-enacted rescheduling of state-licensed medical cannabis is already having broad impacts. The Congressional Research Service published a report on the current cannabis rescheduling move explaining that certified patients who possess medical marijuana from state-licensed dispensaries now have certain protections under Schedule III. “The order appears to authorize end users to possess marijuana for medical use without a CSA-compliant prescription,” it says. The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) has posted a draft update to a gun purchase form to acknowledge the federally legal status of medical marijuana under rescheduling. The revised section in question notably says that only “use or possession of marijuana for recreational purposes” is federally prohibited, leaving out the prior form’s mention of medical cannabis. The U.S. Department of the Treasury and Internal Revenue Service (IRS) said they plan to issue new tax guidance for the marijuana industry following rescheduling. The reform will benefit state-licensed marijuana businesses by allowing them to take federal tax deductions they’re currently barred from under an IRS code known as 280E that doesn’t apply to Schedule III substances. Even DEA, which has long opposed cannabis legalization and was accused of stalling the rescheduling process initiative by the Biden administration, has launched a registration process for state-legal marijuana businesses to take advantage of federal benefits that come with the reform. The Department of Transportation, on the other hand, issued guidance saying that use of state-legal medical cannabis is still no excuse for a positive drug test by truck drivers, pilots and other safety-sensitive workers. A congressional committee recently voted to block federal officials from taking further steps to carry out cannabis rescheduling. Read the letter to the DEA judge from Marijuana Moment’s attorney below: The post Marijuana Moment Asks DEA Judge To Allow Livestreaming Of Rescheduling Hearing For Transparent Public Access appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Medical marijuana is associated with significant improvements in life enjoyment, general activity and physical wellbeing among Minnesota chronic pain patients, according to a new study from researchers at the state’s Office of Cannabis Management (OCM). The peer-reviewed study, published in the journal Clinical Therapeutics, analyzed data from more than 6,000 chronic pain patients in Minnesota’s medical marijuana program from March 2022 to February 2023. It represents a more narrowly tailored review of medical cannabis patient outcomes that OCM published in a broader report last year. Researchers at OCM’s Division of Data and Analytics specifically looked at chronic pain patients who reported participating in the cannabis program for at least eight months, assessing the impact of medical marijuana use based on their on pain, enjoyment of life and general activity, or PEG, score. The latest study iteration also features novel data on product preferences among the pain patient cohort. “Medical cannabis patients report improvement in pain symptoms after four months.” “Patients in the Minnesota Medical Cannabis Program report decreased interference to life enjoyment and general activity from pain symptoms 4 months after starting medical cannabis,” the study found. Specifically, among pain patients with moderate-to-severe PEG scores at the time of enrolling in the cannabis program, 55 percent reported an improvement in life enjoyment of at least 30 percent within four months of their first purchase. Another 55 percent reported improvements to general activity interference and 41 percent said their pain scores improved. What stands out about the study isn’t just that symptoms of pain meaningfully improved within four months of medical cannabis use for patients with the intractable condition; it’s also that, even with pain persisting to some extent, marijuana made life more enjoyable and restored patients’ general functionality. As far as product-specific preferences are concerned, the study authors said high THC:CBD products “were the most commonly purchased in all medical cannabis product categories.” Flower was the most popular product type, followed by vapes and edibles. However, after adjusting for the number of cannabis transactions among patients, the study determined that “there was no significant difference in reduction of PEG scores between purchasing profiles.” “Future research on medical cannabis should determine the frequency of use of different products and administration methods to further investigate how cannabis can be used for effective pain management in patients with chronic pain,” it found. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — The top-level report from OCM that regulators released last year also showed that nearly a quarter of patients who were taking other pain relievers reduced the use of those drugs after using medical marijuana. That’s consistent with a growing body of scientific literature that supported the idea of a substitution effect with marijuana and painkillers, as well as other common pharmaceutical drugs. Meanwhile, separate state data out of Minnesota that was released in April indicates that, despite concerns from legalization opponents who claimed the policy would lead to skyrocketing use by teens, cannabis consumption by middle and high school students in the state is lower now than it has ever been over the past decade. Photo courtesy of Max Pixel. The post Medical Marijuana Significantly Improves Life Enjoyment Among Pain Patients, Study From Minnesota State Officials Shows appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A newly enacted Alaska law will shield people’s marijuana conviction records from being publicly released in certain circumstances. The cannabis provisions are included in a large package of criminal justice legislation that Gov. Mike Dunleavy (R) allowed to become law without his signature on Thursday. Last month, the measure, HB 239, cleared the Senate in a 20-0 vote and was approved by the House of Representatives 39-1. The new law will make it so people who were convicted of possessing less than an ounce of marijuana while over 21 years of age at the time of the offense can request that their records not be released. The protections only apply to people who were not convicted of any other criminal charges in the relevant case. The requirement for someone to proactively request that their records not be released in order for them to remain sealed will be sunsetted on January 1, 2028. The cannabis reform that is now part of the omnibus criminal justice legislation enacted into law was initially introduced as a standalone bill, HB 81 from Rep. David Nelson (R). “In 2014, the state of Alaska voted to legalize the cultivation, sale, and recreational use of marijuana for adults. Despite this change in state law, some Alaskans remain blocked from employment, housing, volunteering, licensing, and other opportunities,” Nelson said in a sponsor statement about the bill. “Hardworking Alaskans could automatically be denied a chance because of previous low level marijuana convictions and employers are potentially deprived of skilled labor in an increasingly dwindling labor market.” “The State cannot afford to pass on skilled labor simply because low level misdemeanors are hindering some Alaskans from pursuing those positions or from finding housing closer to better opportunities,” he said. “This bill will help individuals keep portions of their record confidential while still allowing government agencies access for background and statistical information. Hardworking Alaskans must be given a chance to find redemption for small mistakes and be given the opportunity to make an economic impact like any other citizen.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Separately in Alaska, a government task force recommended earlier this year that the state move forward with plans to provide regulated access to psychedelics if the federal Food and Drug Administration (FDA) authorizes the medical use of substances like psilocybin and MDMA. An activist campaign, meanwhile, announced in December that it failed to collect enough signatures to put an initiative to legalize certain psychedelics such as psilocybin and DMT on the state’s 2026 ballot—but activists emphasized that the “work is far from over” as they shift focus to placing the reform measure before voters in 2028. The post Alaska Bill To Let People Seal Their Marijuana Convictions Becomes Law Without Governor’s Signature appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“Every day that goes by, we’re losing time and availability.” By Zach Wendling, Nebraska Examiner The Nebraska Medical Cannabis Commission cleared the way Monday for the first state-licensed cultivator to put marijuana plants in the ground, while another is taking steps to fight a local zoning decision. The four-member commission voted unanimously to ratify the successful inspection of MahāMotā Cultivation Company in Raymond. This paves the way for the first legal marijuana plants in the state to take root. The commission began meeting last June, and starting Wednesday, the commission will begin accepting applications for product manufacturers. The commission can license four product manufacturers, under agency regulations, which also allow licensing of up to 12 transporters and up to 12 dispensaries. ‘We’re losing time’ Meanwhile, former State Sen. Kent Rogert, a registered lobbyist and sole owner of another licensed cultivator group, KRL Med LLC, said Monday that his company has been stopped in its tracks over a reversal from the Washington County planning and zoning administrator. Rogert said commission staff had been set to inspect the property on May 26, but days before, the county administrator said KRL Med could not use a recommended agricultural exemption to grow marijuana. Hemp, Rogert was told, would qualify, but not marijuana. “Every day that goes by, we’re losing time and availability,” Rogert told commissioners Monday. The former lawmaker said the Washington County rules are “very, very broad, and we definitely fit within that,” but his company is complying with and appealing a stop-work order that also prevents Rogert and his team from going on the property or finishing a greenhouse. Rogert said his group has reached out to the Washington County attorney, but has not heard back. Last year, as state lawmakers considered a broad medical cannabis regulatory bill backed by supporters of the 2024 ballot measure, Nebraska Attorney General Mike Hilgers (R) united dozens of sheriffs and law enforcement organizations in opposition. The Washington County sheriff was one such opponent. Upon questioning from commissioners about whether Rogert’s company could grow this year, Rogert said the “days are ticking away pretty fast,” but, if resolved soon, he’s “cautiously optimistic that we can get something done.” Commissioner J. Michael Coffey of Omaha, a retired district judge, asked whether Rogert would pursue litigation. Rogert said he will go through the local appeal first, outside the courts. Commissioner Lorelle Mueting, interim commission chair, offered to help however Rogert needs, and commissioners voted 4-0 to renew KRL Med LLC’s license for six more months, a sign they are at least OK with Rogert trying to move forward. Two other cultivators Another cultivator, Meadowlark Medicinals, delayed its inspection. Mueting did not give a reason why but said when the cultivator is ready, an inspection can be rescheduled. Commissioners on Monday also approved the request of the fourth and final licensed cultivator, Midwest Cultivator Group, to relocate from Omaha to Gretna. The group also faced changing zoning requirements in Omaha, but a leader of the company, Robert Wagner, said Gretna leaders already approved a requested conditional-use permit for the organization. Wagner said while the company is monitoring the movement of other license types, they will be ready to move forward with a “minimal viable product” when possible and after clearing inspection. Product manufacturer applications Commissioner Jim Elworth of Nebraska City made a successful motion, 3-1, to open up applications for product manufacturers beginning Wednesday. The plan is to solicit applications over the next four weeks and, once the commission can assess application fees, ask applicants to submit the payment and comply with any updated regulations at that time. Elworth said the Legislature appropriating funds for the commission’s work influenced his decision to move ahead, rather than wait for pending regulations to be approved first. “I’m just very concerned about waiting that much longer,” Elworth said. Mueting, the no vote, expressed concern that not accepting application fees would make Nebraska an outlier nationwide for another round of applicants. She was also concerned the application time frame was longer than the previous 19-day period for cultivators last fall. However, Commissioner Bud Synhorst of Lincoln agreed to Elworth’s plan with the idea that applicants could amend their application—or back out—later. Elworth said he will work with commission staff so applicants understand that fees will be charged and that there might be other changes later, such as a willingness to take on transportation duties and amend the planned license type. “Let’s get them in hand so we can deal with them as fairly as possible,” Elworth said. The commission’s next scheduled meeting is 1 p.m. July 20, which would be five days after the current set of temporary regulations expires. The regulations can be extended for 90 days. Regulations await sign off Commissioners in April voted unanimously to advance a formal set of regulations to Hilgers for his signature. Hilgers, who opposes medical marijuana, has not yet signed, but if he does, Gov. Jim Pillen (R) would also need to sign off for the regulations to take effect without an end date. After that, commissioners hope to amend the regulations once again to add application fees, as authorized by the Legislature this spring. Hilgers’s office did not respond to a reporter’s question Monday on the status of the regulations, which were sent to him in mid-April. The issue of medical cannabis is also shaping up to be a hot-button issue for 2026 elections, with Hilgers’s general election opponent, Democrat Jocelyn Brasher, a former assistant attorney general, attending Monday’s meeting to see the commission’s work for the first time. “Today’s meeting made one thing clear: That people and patients in Nebraska deserve more than delay, confusion and dysfunction currently happening under Attorney General Mike Hilgers,” Brasher said after the meeting. “As attorney general, I will uphold the will of the people and respect Nebraska voters on medical cannabis.” Asked about the possible hiccup, should Hilgers not sign in time, Mueting told reporters after the meeting: “We anticipate final regulations to be done by then.” Other agency business In other agency action: The commission will end its agreement with the Nebraska Liquor Control Commission this Friday that had allowed the sharing of office space and staff on a limited basis for almost a year. The overlapping structure largely existed because three of the four commissioners—all but Mueting—also serve on the Liquor Control Commission. The commission will seek permanent office space for dedicated staff and pursue changes to a lease agreement to permanently use a hearing room in downtown Lincoln. A job posting for a commission executive director, with a hiring salary of $100,000, is now public. The commission hired legal counsel. The commission had previously received legal help from the chief legal officer of the Nebraska Department of Health and Human Services, an agency that has long opposed medical cannabis, and, recently, an attorney from the AG’s Office. Commissioners in April said the move was about optics and a possible appearance of “impropriety,” not a judgment on past legal help. This story was first published by Nebraska Examiner. Photo courtesy of Chris Wallis // Side Pocket Images. The post Nebraska Officials Approve Start Of Medical Cannabis Cultivation appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Superior Place, My organization is a great believer during ad opinions regarding online websites that will let the webpage novelists recognize that they’ve put in an item worthwhile that will the online market place! toto togel In fact My partner and i examine that last night yet I needed several feelings regarding it and after this I desired to learn that once more due to the fact it is extremely well written. bandar togel

You may be permitted to blog post details, though not back-links, with regard to they are really sanctioned and even at area. situs toto Surprise! The things a watch opener this approach content is actually in my position. A whole lot highly valued, book marked, Document can’t anticipate a great deal more! hargatoto togel

Thanks for taking the time to discuss this, I feel strongly about it and love learning more on this topic. If possible, as you gain expertise, would you mind updating your blog with extra information? It is extremely helpful for me. pilarhoki

A very awesome blog post. We are really grateful for your blog post. You will find a lot of approaches after visiting your post. pilarhoki slot

“A decision about whether to continue one of the most outdated and destructive drug policies in American history should not exclude the people and advocates most directly affected by it.” By Jason Ortiz, Last Prisoner Project The federal government has finally admitted what millions of people have known for decades: cannabis never belonged in Schedule I. But it’s listening to the wrong voices in deciding how to carry out the process. Schedule I is supposed to be reserved for substances with no accepted medical use and a high potential for abuse. By moving cannabis products produced within state-regulated medical cannabis programs to Schedule III, the government has acknowledged that cannabis has medical value. That admission may be limited, but it cuts through the central justification for keeping cannabis in Schedule I at all. If cannabis no longer fits that category, the criminal penalties tied to its Schedule I status must change too. I have walked the halls of Congress with people who served years, and in some cases decades, for cannabis offenses while legal cannabis businesses opened across the country. I have heard from veterans and patients who fear that using cannabis for pain, trauma or chronic illness could put their freedom at risk. That’s why Last Prisoner Project is petitioning the Drug Enforcement Administration (DEA) to participate in its upcoming hearing on the proposed cannabis rescheduling rule. But the DEA denied our application, along with applications from every other pro-legalization advocacy group in the country. As a result, the only outside voices allowed into the process are organizations that support continued criminalization and the incarceration of people for cannabis offenses. A decision about whether to continue one of the most outdated and destructive drug policies in American history should not exclude the people and advocates most directly affected by it. For any serious federal cannabis reform to be successful and impactful, it must include addressing the damage done to the people who have been incarcerated, supervised, deported, denied opportunity or denied medical access because of prohibition. At Last Prisoner Project, those are the people we work with every day: people coming home after years behind bars, people living with criminal records and families still waiting for relief. Over the last six years, we have helped dismiss, modify or clear more than 250,000 sentences, supported 24 presidential pardons, helped pass 10 bills and worked in 24 states. Alongside our pro bono partners, we have supported thousands of hours of legal work and distributed millions in reentry assistance to people trying to rebuild their lives after cannabis incarceration. But our work is far from finished. One of our constituents, Michael Pelletier, shows what federal prohibition still means in real life. Michael was paralyzed as a teenager after a farm accident and later used marijuana to manage severe pain. In 2006, he was sentenced to life in prison without parole for importing marijuana from Canada. President Trump commuted his sentence in 2021, but Michael still faces the cruelty of federal prohibition. Because marijuana remains federally controlled, he cannot freely use medical cannabis for chronic pain without risking the terms of his supervision. What public safety purpose does that serve? Michael has already lost years of his life to cannabis criminalization. He should not have to choose between pain relief and his freedom. Neither should anyone else. It is time for the federal government to remove cannabis from the Controlled Substances Act entirely, expand clemency and resentencing, clear records, support people coming home and end supervision rules that force patients to choose between medical cannabis and their freedom. As the nation’s cannabis community watches these historic hearings unfold, the question before the country is bigger than whether cannabis belongs in Schedule I or Schedule III. The real question is whether our laws will finally reflect the truth that cannabis prohibition has failed, and the people harmed by that failure deserve relief now. Jason Ortiz is the director of strategic initiatives for Last Prisoner Project, the leading national nonprofit working to free people incarcerated for nonviolent cannabis offenses and repair the harms of criminalization. The post DEA’s Marijuana Rescheduling Hearing Includes The Wrong Voices (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Thank you a bunch for sharing this with all of us you actually realize what you are talking about! Bookmarked. Please also seek advice from my site =). We could have a hyperlink change contract between us! 강남달리는토끼

Two Democratic members of Congress have filed a new bill aimed at supporting marijuana-focused research at Historically Black Colleges and Universities (HBCUs) and Hispanic-Serving Institutions (HSIs). The Establishing and Developing University Cannabis Agriculture Techniques and Excellence (EDUCATE) Act of 2026, filed last week by Reps. Troy Carter (D-LA) and Dina Titus (D-NV), would award grants to fund cannabis research while also creating a new scholarship program to support students who are pursuing careers in marijuana or hemp. Under the legislation, the National Institute of Food and Agriculture under the U.S. Department of Agriculture (USDA) would award grants on a competitive basis to support research on the cultivation and processing of marijuana, including studies focusing on: The optimization of cultivation and harvesting practices for marijuana crops. The examination of soil health, water conservation, pest management, and sustainability impacts of marijuana agriculture. The evaluation of economic development opportunities for minority and disadvantaged farmers in emerging marijuana markets. Workforce development, training, and extension activities related to marijuana agriculture. The bill would authorize the allocation of $5 million a year to fund such research grants from fiscal years 2026 through 2030, with at least 25 percent earmarked for HSIs, and there would be a requirement to give priority to institutions that have partnerships with minority and small-scale farmers or community-based agricultural organizations. The EDUCATE Act also seeks to create a new Marijuana Agriculture Studies Scholarship Program that would award grants of up to $10,000 per year to undergraduate or graduate students at HBCUs and HSIs who are studying food and agricultural sciences and are intending to pursue “a career in marijuana or hemp agriculture, marijuana cultivation, plant science, agricultural technology, agricultural science, or agricultural policy.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — The legislation authorizes USDA to spend up to $100,000 on the scholarships per year for fiscal years 2026 through 2030. The department would need to submit annual reports to Congress on the grants awarded, the studies they funded and participation in the scholarship program. The bill also contains provisions to clarify that institutions of higher education and individuals awarded funding under the new program could not be denied federal benefits or subject to prosecution or civil penalties due to marijuana-related activities in accordance with the legislation. “The legal, responsible use of cannabis has been a major economic driver in Nevada and across the country and deserves further research,” Titus said. “The EDUCATE Act would enable students to explore and study jobs in the cultivation, research, business, and policy sectors of the legal marijuana market by providing federal funding to institutions of higher education.” Read the full text of the new marijuana research and scholarship bill below: The post Feds Would Create Marijuana-Focused Scholarship Program For Students Under New Bill In Congress appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

What a fantabulous post this has been. Never seen this kind of useful post. I am grateful to you and expect more number of posts like these. Thank you very much. M88

Positive site, where did u come up with the information on this posting? I'm pleased I discovered it though, ill be checking back soon to find out what additional posts you include. 강남달리는토끼

It is my first visit to your blog, and I am very impressed with the articles that you serve. Give adequate knowledge for me. Thank you for sharing useful material. I will be back for the more great post. dax69 alternatif

Thank you for taking the time to publish this information very useful! 강남달리는토끼

Military recruit marijuana amendment in Congress; NORML challenges rescheduling non-invite; CA GOP governor candidate on cannabis; Study: CBD for acne Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… BREAKING: Journalism is often consumed for free, but costs money to produce! While this newsletter is proudly sent without cost to you, our ability to send it each day depends on the financial support of readers who can afford to give it. So if you’ve got a few dollars to spare each month and believe in the work we do, please consider joining us on Patreon today. https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW Virginia lawmakers sent Gov. Abigail Spanberger (D) budget legislation that includes provisions to legalize recreational marijuana sales that the governor negotiated with lawmakers after she vetoed a previous plan to enact the reform. Rep. Dave Joyce (R-OH) filed a National Defense Authorization Act amendment to expand marijuana waivers for military recruits by directing the Department of Defense to “develop a program” for people who were not permitted to enlist following a positive THC test “so that such potential enlistees are permitted to reapply.” The National Organization for the Reform of Marijuana Laws is asking the Drug Enforcement Administration to reconsider its decision to exclude the group from participating in the federal cannabis rescheduling hearing starting next week—saying the “public interest will be substantially harmed if the record omits the consumer perspective.” California Republican gubernatorial candidate Steve Hilton told Marijuana Moment that there is a “regulatory burden and a tax burden that is too high” on the cannabis industry—saying it undermines the “goals of legalization, which is a thriving industry that provides a product safely that people want to consume.” A new scientific review concludes that “CBD-containing hemp extracts show biologically plausible and clinically promising adjunctive potential for mild-to-moderate inflammatory acne.” “The current evidence positions CBD-containing hemp extracts as promising adjunctive cosmeceuticals for inflammatory acne.” A Maine Republican representative is launching a campaign to defeat a proposed initiative to roll back marijuana legalization that could appear on the ballot next year. / FEDERAL The U.S. Sentencing Commission published updated fact sheets on cases concerning marijuana and other drugs. Former Rep. Matt Gaetz (R-FL) tweeted, “Every American should be able to enjoy a reasonable amount of weed and guns. Perhaps not together for safety reasons, but definitely individually.” / STATES Florida’s attorney general signed an emergency rule classifying 7-OH compounds under Schedule I. Arkansas’s attorney general praised the U.S. Supreme Court’s ruling on gun rights for marijuana consumers, without directly mentioning cannabis. A Pennsylvania senator tweeted, “Medical marijuana patients shouldn’t automatically lose their Second Amendment rights just for participating in a state-legal program. I’ve worked to try and end that blanket prohibition since 2024, and now the high court agrees it’s too broad.” A New York Senate candidate is pushing to give localities more authority to regulate public marijuana consumption. A lawsuit challenging Oregon’s restrictions on interstate marijuana commerce was dropped by the plaintiffs. Colorado regulators published average market rates for retail marijuana. The Guam Cannabis Control Board will meet on Wednesday. Colorado regulators will hold a hemp rulemaking hearing on June 30. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL Thailand’s government posted an update about enforcement of stricter medical cannabis rules. / SCIENCE & HEALTH A study found that “using data reported by college campuses, we observe that arrests and disciplinary incidents for drug law violations decreased following the legalization of recreational marijuana.” Results of a study of rats “highlight the therapeutic potential of CBD- and THC-containing [cannabis oil] in mitigating early liver damage associated with” metabolic dysfunction-associated steatotic liver disease. / BUSINESS Maryland retailers sold $105 million worth of legal marijuana products in May. / CULTURE Bill Maher cheered the Supreme Court’s decision on marijuana consumers’ gun rights. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Mike Latimer. The post New Virginia legal cannabis sales plan heads to governor’s desk (Newsletter: June 23, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Where sophistication meets desire—book your dream date with Delhi Escort Services tonight. Trained to offer more than companionship, they provide an immersive experience of elegance, sensuality, and intellectual engagement. Let them turn an ordinary evening into an extraordinary affair you will never forget.

125. The Wise Body: What Women's Hormones, Cycles, and Lived Experience Have to Teach Psychedelic Medicine Stephanie Karzon Abrams of Galilea on why psychedelic care must account for women's cycles, life stage, and the knowledge that predates clinical trials. Episode Summary The research on psychedelics was built around male bodies. Women were treated as a confounding variable — their cycles, hormones, and life stages filtered out of study designs rather than centered in them. The result is a clinical landscape where practitioners are guessing, women are underserved, and the knowledge that has existed for generations in women's bodies and lineages is treated as anecdote rather than data. Stephanie Karzon Abrams is the co-creator of Galilea and founder of Beyond Consulting, a practice focused on psychedelic-informed female care: what it requires, what the research does and doesn't tell us, and what women's lived experience is already teaching practitioners who are paying attention. Key Takeaways Hormonal landscape will influence a woman's psychedelic experience — but the research is contradictory enough that we cannot yet say with certainty in what direction. GLP-1 medications slow gastric emptying and interfere with the onset of prodrugs like psilocybin, which must be metabolized into active psilocin in the gut. The distinction between knowledge and knowing is the foundation of the Wise Body framework. Knowledge can be published and replicated. Knowing is generational, intuitive, lived. Psychedelic therapy is more like surgery than a prescription. It requires preparation, skilled practitioners, and mandatory aftercare. We don't yet have adequate data on how diversity, culture, comorbidities, and socioeconomic background affect outcomes. And the ecosystems and communities that hold these medicines are not ready to be scaled. Timestamps Resources Stephanie Karzon Abrams | Galilea, Beyond Consulting Psychedelics & the Whole Self: A Gathering for Womxn Ep. 33 | Therapeutic Psilocybin Use: Tea, Lemon Tek, and Healing Follow April on Substack Visit aprilpride.com Original Substack post: https://aprilpride.substack.com/women-hormones-psychedelics-practitioner-education Hosted by April Pride IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@aprilpridecreates YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠youtube.com/@aprilpridecreates Get full access to APRIL PRIDE at aprilpride.substack.com/subscribeCatch the full episode here

This article is an appealing wealth of useful informative that is interesting and well-written. I commend your hard work on this and thank you for this information. I know it very well that if anyone visits your blog, then he/she will surely revisit it again. pilarhoki